| 1 | [SID852220] | Active | IC50 | 4.901 | Anti-Viral Drugs Against Arbovirus Infections, a Confirmatory Screen [AID1250, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | IC50 | 4.901 [uM] | | BioAssay | Anti-Viral Drugs Against Arbovirus Infections, a Confirmatory Screen | | AID | 1250 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID852220] | Active | EC50 | 10.9 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | EC50 | 10.9 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 3 | [SID852220] | Active | EC50 | 11.022 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | EC50 | 11.022 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID852220] | Active | IC50 | 14.74 | Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Confirmatory Screen [AID1361, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | IC50 | 14.74 [uM] | | BioAssay | Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Confirmatory Screen | | AID | 1361 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID852220] | Active | EC50 | 17.258 | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus [AID1915, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | EC50 | 17.258 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus | | AID | 1915 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID852220] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID852220] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID852220] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID852220] | Active | | | Second counter screen for compounds that modulate the two-pore domain potassium channel (KCNK9) [AID492997, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Second counter screen for compounds that modulate the two-pore domain potassium channel (KCNK9) | | AID | 492997 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 10 | [SID852220] | Active | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 [AID488922, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 | | AID | 488922 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 11 | [SID852220] | Active | | | Confirmatory screen for identification of compounds that inhibit the two-pore domain potassium channel (KCNK9) [AID492992, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Confirmatory screen for identification of compounds that inhibit the two-pore domain potassium channel (KCNK9) | | AID | 492992 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 12 | [SID852220] | Active | | | Specificity screen against KCNQ1/KCNE1 for identification of compounds that inhibit KCNQ1 potassium channels [AID652147, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ1/KCNE1 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 652147 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 13 | [SID852220] | Active | | | MLPCN Streptokinase Expression Inhibition [AID1662, Type: screening] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | MLPCN Streptokinase Expression Inhibition | | AID | 1662 | | BioAssay type | screening | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 14 | [SID852220] | Active | | | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels [AID651746, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 651746 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 15 | [SID852220] | Active | | | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels [AID651746, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ2 for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 651746 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 16 | [SID852220] | Active | | | Colorimetric Assay for Inhibitors for NALP1 [AID2071, Type: screening] | NACHT, LRR and PYD domains-containing protein 1 isoform 1 [Homo sapiens] [gi:14719829] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Colorimetric Assay for Inhibitors for NALP1 | | AID | 2071 | | BioAssay type | screening | | Target | NACHT, LRR and PYD domains-containing protein 1 isoform 1 [Homo sapiens] [gi:14719829] | | PubMed | | | Data Table |  |
|
| 17 | [SID852220] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 18 | [SID852220] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 19 | [SID852220] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 20 | [SID852220] | Active | | | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) [AID602282, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) | | AID | 602282 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 21 | [SID852220] | Active | | | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) [AID602282, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) | | AID | 602282 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 22 | [SID852220] | Active | | | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) [AID602282, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that activate the regulator of G-protein signaling 4 (RGS4) | | AID | 602282 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 23 | [SID852220] | Active | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [AID602410, Type: screening] | Kcnk3 channel [Homo sapiens] [gi:11093520] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 | | AID | 602410 | | BioAssay type | screening | | Target | Kcnk3 channel [Homo sapiens] [gi:11093520] | | PubMed | | | Data Table |  |
|
| 24 | [SID852220] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 25 | [SID852220] | Active | | | Validation (re-confirmation) assay for identification of compounds that inhibit KCNQ1 potassium channels [AID588353, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Validation (re-confirmation) assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 588353 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 26 | [SID852220] | Active | | | HIV-1 RT-RNase H MLSCN HTS MH077605 [AID565, Type: screening] | Chain A, Hiv-1 Reverse Transcriptase Mol_id: 1; Molecule: Hiv-1 Reverse Transcriptase; Chain: A, B; [gi:1431733] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | HIV-1 RT-RNase H MLSCN HTS MH077605 | | AID | 565 | | BioAssay type | screening | | Target | Chain A, Hiv-1 Reverse Transcriptase Mol_id: 1; Molecule: Hiv-1 Reverse Transcriptase; Chain: A, B; [gi:1431733] | | PubMed | | | Data Table |  |
|
| 27 | [SID852220] | Active | | | Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen [AID1362, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen | | AID | 1362 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID852220] | Active | | | Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen [AID1251, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen | | AID | 1251 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID852220] | Active | | | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen [AID598, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen | | AID | 598 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID852220] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 31 | [SID852220] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 32 | [SID852220] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 33 | [SID852220] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 34 | [SID852220] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 35 | [SID852220] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 36 | [SID852220] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID852220] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 38 | [SID852220] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 39 | [SID852220] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 40 | [SID852220] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 41 | [SID852220] | Inactive | Potency | 5.2213 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | Potency | 5.2213 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID852220] | Inactive | Potency | 17.7828 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 43 | [SID852220] | Inactive | Potency | 17.7828 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 44 | [SID852220] | Inactive | Potency | 35.4813 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 45 | [SID852220] | Inactive | Potency | 35.4813 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 46 | [SID852220] | Inactive | Potency | 89.1251 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 47 | [SID852220] | Inactive | EC50 | 150 | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression [AID1914, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | EC50 | 150 [uM] | | BioAssay | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression | | AID | 1914 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 48 | [SID852220] | Inactive | | | HTS to identify Inhibitors of West Nile Virus NS2bNS3 Proteinase [AID577, Type: screening] | polyprotein precursor [West Nile virus] [gi:11528014] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | BioAssay | HTS to identify Inhibitors of West Nile Virus NS2bNS3 Proteinase | | AID | 577 | | BioAssay type | screening | | Target | polyprotein precursor [West Nile virus] [gi:11528014] | | PubMed | | | Data Table |  |
|
| 49 | [SID852220] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) [AID602123, Type: screening] | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) | | AID | 602123 | | BioAssay type | screening | | Target | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] | | PubMed | | | Data Table |  |
|
| 50 | [SID852220] | Inactive | | | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay [AID504720, Type: screening] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 852220 | | CID | 54677080 | | Outcome | Inactive | | BioAssay | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay | | AID | 504720 | | BioAssay type | screening | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|